REMINDER: Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd.
November 19, 2019 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) today announced that it has entered into a global agreement with Idorsia Pharmaceuticals Ltd....
Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd.
November 19, 2019 01:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) today announced that it has entered into a global agreement with Idorsia Pharmaceuticals Ltd....
Antares Pharma to Present at the Jefferies 2019 London Healthcare Conference
November 13, 2019 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies 2019...
Antares Pharma Reports Third Quarter 2019 Operating and Financial Results
November 05, 2019 07:00 ET
|
Antares Pharma, Inc.
Record Quarterly Revenue of $34.3 Million – Earnings Per Share of $0.01 The Company Increases Full Year 2019 Revenue Guidance to a Range of $115.0 to $120.0 Million EWING, N.J., Nov. 05, 2019 ...
Antares Pharma Announces Receipt of Final Payment From Sale of Zomajet™ Needle-Free Delivery System
October 31, 2019 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares” or “Company”) today announced that it has received the final payment of $2.5 million from Ferring...
Antares Pharma to Report Third Quarter 2019 Financial and Operating Results
October 29, 2019 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its third quarter 2019 financial results and recent operating progress before the...
Antares Pharma Announces Two Poster Presentations at the 2019 Sexual Medicine Society Scientific Annual Meeting
October 24, 2019 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that data from two poster presentations will be presented on Saturday October 26, 2019 at the 20th...
Antares Pharma to Present at the Ladenburg Thalmann 2019 Healthcare Conference
September 17, 2019 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Ladenburg...
Antares Pharma Reports Second Quarter 2019 Operating and Financial Results
August 06, 2019 07:00 ET
|
Antares Pharma, Inc.
Record Quarterly Revenue of $28.4 Million - Double Second Quarter 2018 Revenue The Company Increases Full Year 2019 Revenue Guidance to a Range of $100.0 to $110.0 Million EWING, N.J., Aug. 06,...
Antares Pharma to Report Second Quarter 2019 Financial and Operating Results
July 30, 2019 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., July 30, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its second quarter 2019 financial results and recent operating progress before the...